Rxsight Inc
NASDAQ:RXST
Rxsight Inc
NASDAQ:RXST
Price:
7.39
USD
-1.6%
Market Closed
Market Cap:
$303.9m
Balance Sheet
Balance Sheet Decomposition
Rxsight Inc
Rxsight Inc
Balance Sheet Decomposition is not available for
Rxsight Inc
Rxsight Inc
Balance Sheet
Rxsight Inc
Rxsight Inc
Currency: USD
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
8
|
14
|
24
|
12
|
10
|
17
|
20
|
|
| Cash Equivalents |
8
|
14
|
24
|
12
|
10
|
17
|
20
|
|
| Short-Term Investments |
73
|
55
|
135
|
94
|
117
|
221
|
208
|
|
| Total Receivables |
1
|
3
|
5
|
11
|
20
|
30
|
23
|
|
| Accounts Receivables |
1
|
3
|
5
|
11
|
20
|
30
|
23
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
7
|
8
|
8
|
15
|
17
|
22
|
32
|
|
| Other Current Assets |
2
|
1
|
4
|
3
|
4
|
5
|
4
|
|
| Total Current Assets |
90
|
82
|
176
|
135
|
168
|
294
|
287
|
|
| PP&E Net |
19
|
19
|
16
|
14
|
13
|
24
|
23
|
|
| PP&E Gross |
19
|
19
|
16
|
14
|
13
|
24
|
23
|
|
| Accumulated Depreciation |
9
|
12
|
16
|
20
|
23
|
25
|
27
|
|
| Other Long-Term Assets |
1
|
1
|
1
|
2
|
1
|
1
|
1
|
|
| Total Assets |
110
N/A
|
101
-9%
|
193
+91%
|
150
-22%
|
183
+22%
|
319
+75%
|
312
-2%
|
|
| Liabilities | ||||||||
| Accounts Payable |
2
|
1
|
2
|
3
|
4
|
5
|
5
|
|
| Accrued Liabilities |
6
|
5
|
9
|
11
|
12
|
15
|
12
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Liabilities |
0
|
6
|
1
|
4
|
5
|
6
|
9
|
|
| Total Current Liabilities |
9
|
12
|
11
|
17
|
21
|
26
|
26
|
|
| Long-Term Debt |
0
|
24
|
40
|
40
|
0
|
0
|
0
|
|
| Other Liabilities |
79
|
9
|
4
|
3
|
1
|
11
|
10
|
|
| Total Liabilities |
88
N/A
|
45
-49%
|
55
+21%
|
60
+11%
|
22
-63%
|
37
+68%
|
36
-3%
|
|
| Equity | ||||||||
| Common Stock |
384
|
434
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
360
|
378
|
479
|
546
|
595
|
622
|
661
|
|
| Additional Paid In Capital |
0
|
0
|
618
|
636
|
755
|
903
|
937
|
|
| Other Equity |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
23
N/A
|
56
+143%
|
138
+148%
|
90
-35%
|
160
+78%
|
281
+75%
|
276
-2%
|
|
| Total Liabilities & Equity |
110
N/A
|
101
-9%
|
193
+91%
|
150
-22%
|
183
+22%
|
319
+75%
|
312
-2%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
26
|
26
|
27
|
28
|
36
|
40
|
41
|
|
Switch to:
Switch to:
See Also
Discover More
